| Serial Number | 97627400 |
| Word Mark | GQ |
| Filing Date | Tuesday, October 11, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 6, 2024 |
| Registration Number | 7465095 |
| Registration Date | Tuesday, August 6, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 21, 2024 |
| Goods and Services | Vaccines; Analgesic preparations; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-inflammatory preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological skin tissues, liver tissues, and joint tissues, namely, bone, cartilage, synovium, and tendon tissues, all intended for subsequent implantation; Cells for medical or clinical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical or veterinary purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Human vaccine preparations; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pain relief medication; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment and prevention of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary pharmaceutical preparations for the prevention of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, pulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary pharmaceutical preparations for the treatment of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, pulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Veterinary preparations, namely, pain relief medication; Veterinary vaccines; In vitro diagnostic preparations for medical use |
| Goods and Services | Consulting services in the field of pharmaceutical research and development; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development in the field of genetics, gene therapy, cell therapy, vaccines, biotechnological production, non-viral and viral vector production; Pharmaceutical drug development services for prevention and treatment of musculoskeletal, genetic, ophthalmic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Scientific research and development; Scientific research consulting in the field of genetics, gene therapy, cell therapy, vaccines, biotechnological production, and non-viral and viral vector production; Scientific research for medical purposes in the field of musculoskeletal, genetic, metabolic, endocrine, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, nephrological, hematological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, infectious, dermatological, and immune system related diseases and disorders; Scientific research in the field of genetics and genetic engineering; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| Goods and Services | Biomanufacturing for others, namely, manufacturing of biologics, vaccines, non-viral and viral vectors, and gene and cell therapy preparations, all using biological organisms in the manufacturing process; Custom manufacture of pharmaceuticals, biologics, vaccines, biotechnological products, non-viral and viral vectors, and gene and cell therapy preparations by pharmaceutical compounders; Custom manufacture of pharmaceuticals, biologics, vaccines, biotechnological medications, non-viral and viral vectors, and gene and cell therapy preparations; Manufacturing process consulting; Manufacturing services for others in the field of pharmaceuticals, biologics, vaccines, non-viral and viral vectors, and gene therapy and gene and cell therapy preparations; Technical support services, namely, providing technical advice related to the manufacture of biologics, gene therapy preparations, vaccines, non-viral and viral vectors |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 26, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 26, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 26, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | PACIRA GERMANY GMBH |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | HAMBURG 20095 DE |
| Party Name | GQ BIO THERAPEUTICS GMBH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | HAMBURG 20095 DE |
| Party Name | GQ BIO THERAPEUTICS GMBH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | HAMBURG 21079 DE |
| Party Name | GQ BIO THERAPEUTICS GMBH |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | HAMBURG 21079 DE |
| Party Name | GeneQuine Biotherapeutics GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hamburg 21079 DE |
| Event Date | Event Description |
| Friday, October 14, 2022 | NEW APPLICATION ENTERED |
| Wednesday, October 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 26, 2023 | ASSIGNED TO EXAMINER |
| Monday, August 14, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, August 14, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, August 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 23, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, August 31, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 22, 2024 | ASSIGNED TO LIE |
| Monday, January 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 21, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 21, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 1, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 21, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 6, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 6, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 20, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 20, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, August 20, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, August 20, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, August 20, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, August 20, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, October 1, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 1, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 1, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, December 1, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |